Deutsche Bank analysts upgrades a Buy rating for Acadia Pharmaceuticals Inc (ACAD)

Acadia Pharmaceuticals Inc’s recently made public that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $90000.0 on May 16 ’25. In the deal valued at $22.50 per share,4,000 shares were sold. As a result of this transaction, Kihara James now holds 20,395 shares worth roughly $0.44 million.

Then, Schneyer Mark C. sold 2,000 shares, generating $50,000 in total proceeds. Upon selling the shares at $25.00, the EVP, CHIEF FINANCIAL OFFICER now owns 62,130 shares.

Before that, Schneyer Mark C. bought 2,000 shares. Acadia Pharmaceuticals Inc shares valued at $35,200 were divested by the Officer at a price of $17.60 per share.

Deutsche Bank upgraded its Acadia Pharmaceuticals Inc [ACAD] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Hold”‘ rating. Guggenheim also remained covering ACAD and has decreased its forecast on January 03, 2025 with a “Neutral” recommendation from previously “Buy” rating.

Price Performance Review of ACAD

On Monday, Acadia Pharmaceuticals Inc [NASDAQ:ACAD] saw its stock fall -0.49% to $21.47. Over the last five days, the stock has lost -2.34%. Acadia Pharmaceuticals Inc shares have risen nearly 16.98% since the year began. Nevertheless, the stocks have risen 46.82% over the past one year. While a 52-week high of $25.23 was reached on 05/16/25, a 52-week low of $13.40 was recorded on 04/09/25. SMA at 50 days reached $17.01, while 200 days put it at $16.90.

Levels Of Support And Resistance For ACAD Stock

The 24-hour chart illustrates a support level at 21.13, which if violated will result in even more drops to 20.79. On the upside, there is a resistance level at 21.77. A further resistance level may holdings at 22.07. The Relative Strength Index (RSI) on the 14-day chart is 67.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.86, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.58%. Stochastics %K at 58.67% indicates the stock is a holding.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.